Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species.

The objective of this study was to evaluate the effect of the bacterial endotoxin LPS on Candida biofilm formation in vitro. The effect of the LPS of Pseudomonas aeruginosa, Klebsiella pneumoniae, Serratia marcescens and Salmonella typhimurium on six different species of Candida, comprising Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, Candida tropicalis ATCC 13803, Candida parapsilosis ATCC 22019 and Candida dubliniensis MYA 646, was studied using a standard biofilm assay. The metabolic activity of in vitro Candida biofilms treated with LPS at 90 min, 24 h and 48 h was quantified by XTT reduction assay. Viable biofilm-forming cells were qualitatively analysed using confocal laser scanning microscopy (CLSM), while scanning electron microscopy (SEM) was employed to visualize the biofilm structure. Initially, adhesion of C. albicans was significantly stimulated by Pseudomonas and Klebsiella LPS. A significant inhibition of Candida adhesion was noted for the following combinations: C. glabrata with Pseudomonas LPS, C. tropicalis with Serratia LPS, and C. glabrata, C. parapsilosis or C. dubliniensis with Salmonella LPS (P<0.05). After 24 h of incubation, a significant stimulation of initial colonization was noted for the following combinations: C. albicans/C. glabrata with Klebsiella LPS, C. glabrata/C. tropicalis/C. krusei with Salmonella LPS. In contrast, a significant inhibition of biofilm formation was observed in C. glabrata/C. dubliniensis/C. krusei with Pseudomonas LPS, C. krusei with Serratia LPS, C. dubliniensis with Klebsiella LPS and C. parapsilosis/C. dubliniensis /C. krusei with Salmonella LPS (P<0.05). On further incubation for 48 h, a significant enhancement of biofilm maturation was noted for the following combinations: C. glabrata/C. tropicalis with Serratia LPS, C. dubliniensis with Klebsiella LPS and C. glabrata with Salmonella LPS, and a significant retardation was noted for C. parapsilosis/C. dubliniensis/C. krusei with Pseudomonas LPS, C. tropicalis with Serratia LPS, C. glabrata/C. parapsilosis/C. dubliniensis with Klebsiella LPS and C. dubliniensis with Salmonella LPS (P<0.05). These findings were confirmed by SEM and CLSM analyses. In general, the inhibition of the biofilm development of LPS-treated Candida spp. was accompanied by a scanty architecture with a reduced numbers of cells compared with the profuse and densely colonized control biofilms. These data are indicative that bacterial LPSs modulate in vitro Candida biofilm formation in a species-specific and time-dependent manner. The clinical and the biological relevance of these findings have yet to be explored.

[1]  D. Morrison,et al.  Activation of murine spleen cells by lipid A: negative modulation of lipid A mitogenic activity by O-antigen polysaccharide. , 1985, Journal of immunology.

[2]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[3]  R. McLean,et al.  Methods of Studying Biofilms , 2004 .

[4]  J. Djeu,et al.  Lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides: relationship to growth inhibition of Candida albicans , 1992, Infection and immunity.

[5]  R. Wenzel,et al.  Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  F. Bongard,et al.  Candida sepsis in surgical patients. , 1993, American journal of surgery.

[7]  D. Morrison,et al.  Comparable Endotoxic Properties of Lipopolysaccharides Are Manifest in Diverse Clinical Isolates of Gram-Negative Bacteria , 2000, Infection and Immunity.

[8]  C. Kauffman,et al.  Epidemiology of Yeast Colonization in the Intensive Care Unit , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[9]  L. Samaranayake,et al.  The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms , 2005, Mycopathologia.

[10]  A. Zeng,et al.  Alterations in the formation of lipopolysaccharide and membrane vesicles on the surface of Pseudomonas aeruginosa PAO1 under oxygen stress conditions. , 2003, Microbiology.

[11]  R. Kolter,et al.  Biofilm formation as microbial development. , 2000, Annual review of microbiology.

[12]  D. Snydman.  Shifting patterns in the epidemiology of nosocomial Candida infections. , 2003, Chest.

[13]  G. T. McIntyre.  Oral candidosis. , 2001, Dental update.

[14]  J. Mcghee,et al.  The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. , 1980, The Journal of infectious diseases.

[15]  J. Vincent,et al.  Potential risk factors for infection with Candida spp. in critically ill patients. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  D. Hess,et al.  Escherichia coli and TNF-alpha modulate macrophage phagocytosis of Candida glabrata. , 2009, The Journal of surgical research.

[17]  W. Powderly,et al.  A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  D. Morrison,et al.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. , 1975, The Journal of biological chemistry.

[19]  L. Jl.  Gram-negative sepsis. , 1976, Delaware medical journal.

[20]  L. Samaranayake,et al.  Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. , 2004, Archives of oral biology.

[21]  T. Beveridge,et al.  Pseudomonas aeruginosa PAO1 ceases to express serotype-specific lipopolysaccharide at 45 degrees C , 1996, Journal of bacteriology.

[22]  D. Dunn,et al.  Candida albicans and Escherichia coli are synergistic pathogens during experimental microbial peritonitis. , 1997, The Journal of surgical research.

[23]  M. S. Rangel-Frausto,et al.  The epidemiology of bacterial sepsis. , 1999, Infectious disease clinics of North America.

[24]  E. Rietschel,et al.  Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. , 1982, Scandinavian journal of infectious diseases. Supplementum.

[25]  B. Wickes,et al.  Characteristics of biofilm formation by Candida albicans. , 2001, Revista iberoamericana de micologia.

[26]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  D. Jacobs,et al.  Isolation of a lipid a bound polypeptide responsible for “LPS- initiated” mitogenesis of C3H/HeJ spleen cells , 1976, The Journal of experimental medicine.

[28]  D. Morrison,et al.  Endotoxins and disease mechanisms. , 1987, Annual review of medicine.

[29]  J. Carrizosa.  Gram-negative sepsis. , 1976, Journal of the American Medical Women's Association.

[30]  C. S. Raymond,et al.  Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. , 1992, The Journal of surgical research.

[31]  G. O’Toole,et al.  Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.

[32]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[33]  L. Samaranayake,et al.  Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. , 2009, Journal of medical microbiology.

[34]  G. Akagawa,et al.  Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. , 1995, The Journal of infectious diseases.

[35]  M. Pfaller.  Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  H. Jenkinson,et al.  Interactions between Candida Species and Bacteria in Mixed Infections , 2002 .

[37]  D. Morrison,et al.  Structural requirements for gelation of the Limulus amebocyte lysate by endotoxin. , 1987, Progress in clinical and biological research.

[38]  D. Hess,et al.  Effect of lipopolysaccharide on virulence of intestinal candida albicans. , 2003, The Journal of surgical research.

[39]  A. Mitchell,et al.  Microbial biofilms: e pluribus unum , 2007, Current Biology.

[40]  C A Aurell,et al.  Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS). , 1998, Biochemical and biophysical research communications.

[41]  D. Pittet,et al.  Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. , 1995, Archives of internal medicine.